These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32910055)

  • 21. Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis.
    Sadaghiani MS; Roman S; Diaz-Arias LA; Habis R; Venkatesan A; Probasco JC; Solnes LB
    Neuroradiology; 2023 Aug; 65(8):1225-1238. PubMed ID: 37264220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of PET/CT with
    Alarcón L; López-Mora D; Fernández A; Carrió I; Camacho V
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(3):173-174. PubMed ID: 31836566
    [No Abstract]   [Full Text] [Related]  

  • 23. Striatal hypermetabolism in limbic encephalitis.
    Rey C; Koric L; Guedj E; Felician O; Kaphan E; Boucraut J; Ceccaldi M
    J Neurol; 2012 Jun; 259(6):1106-10. PubMed ID: 22081102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of limbic encephalitis in the cancer patient.
    Kyritsis AP; Markoula S; Alexiou G; Asimakopoulos A; Jabbour P; Fotopoulos A; Sioka C
    Future Oncol; 2020 Aug; 16(22):1647-1655. PubMed ID: 32511017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three cases of antibody-LGI1 limbic encephalitis and review of literature.
    Bing-Lei W; Jia-Hua Z; Yan L; Zan Y; Xin B; Jian-Hua S; Hui-Juan W
    Int J Neurosci; 2019 Jul; 129(7):642-648. PubMed ID: 30112956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Value of
    Solnes LB; Jones KM; Rowe SP; Pattanayak P; Nalluri A; Venkatesan A; Probasco JC; Javadi MS
    J Nucl Med; 2017 Aug; 58(8):1307-1313. PubMed ID: 28209905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-NMDAR (N-methy-D-aspartate receptor) limbic encephalitis diagnosed by ¹⁸F-FDG PET/CT].
    Garcia JR; Saura J; Flor A; Soler M; Moragas M; Lorenzo-Bosquet C
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):143-5. PubMed ID: 25049159
    [No Abstract]   [Full Text] [Related]  

  • 28. Brain metabolic changes in limbic encephalitis evidenced by 18FDG PET. Correlation with symptomatology.
    Serrano Vicente J; García Bernardo L; Durán Barquero C; Infante Torre JR; Rayo Madrid JI; Domínguez Grande ML
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):201-2. PubMed ID: 23266009
    [No Abstract]   [Full Text] [Related]  

  • 29. Successive affection of bilateral temporomesial structures in a case of non-paraneoplastic limbic encephalitis demonstrated by serial MRI and FDG-PET.
    Chatzikonstantinou A; Szabo K; Ottomeyer C; Kern R; Hennerici MG
    J Neurol; 2009 Oct; 256(10):1753-5. PubMed ID: 19434439
    [No Abstract]   [Full Text] [Related]  

  • 30. Different FDG-PET metabolic patterns of anti-AMPAR and anti-NMDAR encephalitis: Case report and literature review.
    Wei YC; Tseng JR; Wu CL; Su FC; Weng WC; Hsu CC; Chang KH; Wu CF; Hsiao IT; Lin CP
    Brain Behav; 2020 Mar; 10(3):e01540. PubMed ID: 31985135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune Encephalitis Concomitant with SARS-CoV-2 Infection: Insight from
    Grimaldi S; Lagarde S; Harlé JR; Boucraut J; Guedj E
    J Nucl Med; 2020 Dec; 61(12):1726-1729. PubMed ID: 32709734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermetabolism of the medial temporal lobe in limbic encephalitis on (18)FDG-PET scan: a case report.
    Na DL; Hahm DS; Park JM; Kim SE
    Eur Neurol; 2001; 45(3):187-9. PubMed ID: 11306867
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on the diagnosis of encephalitis.
    Arbizu J; Gállego Pérez-Larraya J; Hilario A; Gómez Grande A; Rubí S; Camacho V;
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(4):247-257. PubMed ID: 35701317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.
    Lai M; Huijbers MG; Lancaster E; Graus F; Bataller L; Balice-Gordon R; Cowell JK; Dalmau J
    Lancet Neurol; 2010 Aug; 9(8):776-85. PubMed ID: 20580615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic Limbic Encephalitis Secondary to SCLC on 18F-FDG PET/CT.
    Verçosa AFA; Mota IA; Flamini MEDM; Flamini RC
    Clin Nucl Med; 2021 Jun; 46(6):494-496. PubMed ID: 33939650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare case of autoimmune limbic encephalitis: an uncharted territory!
    Ibrahim H; Al Jasser AN; Khan SA; Tlili KG
    Neurosciences (Riyadh); 2017 Oct; 22(4):292-297. PubMed ID: 29057855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlative imaging with (18)F-FDG PET/CT and MRI in paraneoplastic limbic encephalitis.
    Maffione AM; Chondrogiannis S; Ferretti A; Al-Nahhas A; Rubello D
    Clin Nucl Med; 2013 Jun; 38(6):463-4. PubMed ID: 23531769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of brain fluorodeoxyglucose PET in children with possible autoimmune encephalitis.
    Aydos U; Arhan E; Akdemir ÜÖ; Akbaş Y; Aydin K; Atay LÖ; Serdaroğlu A
    Nucl Med Commun; 2020 Aug; 41(8):800-809. PubMed ID: 32459714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated microglia by
    Wang J; Jin L; Zhang X; Yu H; Ge J; Deng B; Li M; Zuo C; Chen X
    J Neuroimmunol; 2022 Jul; 368():577879. PubMed ID: 35504188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide-responsive Lgi1-related limbic encephalitis with basal ganglia hypermetabolism.
    Renard D; Collombier L; Lippi A; Honnorat J; Thouvenot E
    Acta Neurol Belg; 2016 Sep; 116(3):379-81. PubMed ID: 26590598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.